End-to-End Product Development
How Vici Can Help
- Product Selection and Evaluation
- Product Development for Passing FDA Bioequivalence
- Ability to Handle DEA Schedule II-V and Cytotoxic Drugs
Oral Solutions, suspensions, ER suspensions, powders for reconstitution
Tablets, capsules, modified release, osmotic technology, mini tablets, abuse deterrent formulations
Injectable products including complex and potent compounds
Ophthalmic solutions and suspensions